<?xml version="1.0" encoding="UTF-8"?>
<ref id="bph15092-bib-0093">
 <mixed-citation publication-type="journal" id="bph15092-cit-0094">
  <string-name>
   <surname>Verhoeven</surname>, 
   <given-names>M. M.</given-names>
  </string-name>, 
  <string-name>
   <surname>de Hair</surname>, 
   <given-names>M. J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Tekstra</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Bijlsma</surname>, 
   <given-names>J. W.</given-names>
  </string-name>, 
  <string-name>
   <surname>van Laar</surname>, 
   <given-names>J. M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Pethoe‐Schramm</surname>, 
   <given-names>A.</given-names>
  </string-name>, … 
  <string-name>
   <surname>Welsing</surname>, 
   <given-names>P. M.</given-names>
  </string-name> (
  <year>2019</year>). 
  <article-title>Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step‐up treatment strategies in early rheumatoid arthritis: An indirect comparison of effectiveness and safety of the U‐Act‐Early and CAMERA‐II treat‐to‐target trials</article-title>. 
  <source xml:lang="en">Annals of the Rheumatic Diseases</source>, 
  <volume>78</volume>(
  <issue>10</issue>), 
  <fpage>1333</fpage>–
  <lpage>1338</lpage>. 
  <pub-id pub-id-type="doi">10.1136/annrheumdis-2019-215304</pub-id>
  <pub-id pub-id-type="pmid">31196844</pub-id>
 </mixed-citation>
</ref>
